Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantification of liver function using gadoxetic acid-enhanced MRI. | Abdom Radiol (NY) | 2020 | 33034671 | PubTator, text mining | PubMed |
| Development of a novel molecular probe for the detection of liver mitochondrial redox metabolism. | Sci Rep | 2020 | 33020535 | PubTator, text mining | PubMed |
| Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study. | Front Endocrinol (Lausanne) | 2020 | 33013699 | PubTator, text mining | PubMed |
| The Development and Validation of a Novel "Dual Cocktail" Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions. | Pharmaceutics | 2020 | 33007943 | PubTator, text mining | PubMed |
| Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer. | Oncol Lett | 2020 | 32994815 | PubTator, text mining | PubMed |
| Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters. | Pharmaceutics | 2020 | 32992777 | PubTator, text mining | PubMed |
| Synergistic transport of a fluorescent coumarin probe marks coumarins as pharmacological modulators of Organic anion-transporting polypeptide, OATP3A1. | Biochem Pharmacol | 2020 | 32991865 | PubTator, text mining | PubMed |
| Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes. | Int J Mol Sci | 2020 | 32987693 | PubTator, text mining | PubMed |
| Quantitative Fundus Autofluorescence in HCQ Retinopathy. | Invest Ophthalmol Vis Sci | 2020 | 32976563 | PubTator, text mining | PubMed |
| Effects of perfluoroalkyl carboxylic acids on the uptake of sulfobromophthalein via organic anion transporting polypeptides in human intestinal Caco-2 cells. | Biochem Biophys Rep | 2020 | 32964147 | PubTator, text mining | PubMed |
| Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis. | PLoS One | 2020 | 32956413 | PubTator, text mining | PubMed |
| Review: Pathogenesis of cholestatic liver diseases. | World J Hepatol | 2020 | 32952871 | PubTator, text mining | PubMed |
| Exposure-Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis-Associated Pain. | CPT Pharmacometrics Syst Pharmacol | 2020 | 32945631 | PubTator, text mining | PubMed |
| Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers. | Oncotarget | 2020 | 32934776 | PubTator, text mining | PubMed |
| Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. | Cancers (Basel) | 2020 | 32933095 | PubTator, text mining | PubMed |
| Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study. | Stem Cell Res Ther | 2020 | 32917265 | PubTator, text mining | PubMed |
| Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors. | Pharmaceutics | 2020 | 32916864 | PubTator, text mining | PubMed |
| Polymethine Dye-Functionalized Nanoparticles for Targeting CML Stem Cells. | Mol Ther Oncolytics | 2020 | 32913887 | PubTator, text mining | PubMed |
| Pharmacogenomics of COVID-19 therapies. | NPJ Genom Med | 2020 | 32864162 | PubTator, text mining | PubMed |
| Cannabidiol protects keratinocyte cell membranes following exposure to UVB and hydrogen peroxide. | Redox Biol | 2020 | 32863232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=50